Article
Sage's depression drug improves symptoms, but durability concerns sink shares
Rating:
0.0
Views:
82
Likes:
1
Library:
1
Sage Therapeutics Inc's drug helped improve depressive symptoms after three days in a late-stage study, but investor concerns over how long the treatment's effect would last sent the drug developer's shares down 17% on Wednesday.
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value